Literature DB >> 28282344

How to evaluate and assess quality of life issues in head and neck cancer patients.

Jose G Vartanian1, Simon N Rogers, Luiz P Kowalski.   

Abstract

PURPOSE OF REVIEW: Review quality of life (QOL) concepts and most common instruments to be used in patients with head and neck cancer, as well as the potential benefits and limitations of information derived from QOL studies. RECENT
FINDINGS: Information from QOL studies can be clinical predictors of prognosis, serve as potential screening and planning tools for clinical care and rehabilitation efforts. Enhancements in computer technology and the advent of tools like head and neck cancer-specific item prompt list will allow for QOL data to be used more easily.
SUMMARY: Patients with malignant head and neck neoplasms can present changes in important vital functions related to the disease and its treatment, usually resulting in a negative impact on their QOL. The application of specific questionnaires can be used to measure such impact and the information derived from QOL studies has the potential to be incorporated in the clinical practice to improve the quality of care.

Entities:  

Year:  2017        PMID: 28282344     DOI: 10.1097/CCO.0000000000000369

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  5 in total

1.  Can post-treatment oral cancer patients' concerns reflect their cancer characteristics, HRQoL, psychological distress level and satisfaction with consultation?

Authors:  Ainon Natrah Aminnudin; Jennifer Geraldine Doss; Siti Mazlipah Ismail; Ma Bee Chai; Marzuki Zainal Abidin; Cri Saiful Jordan Milano Basri; Nurshaline Pauline Kipli; Lee Chee Wei
Journal:  Ecancermedicalscience       Date:  2020-10-08

Review 2.  Using PROMs to guide patients and practitioners through the head and neck cancer journey.

Authors:  Simon N Rogers; Brittany Barber
Journal:  Patient Relat Outcome Meas       Date:  2017-11-08

3.  Factors associated with the quality of life of subjects with facial disfigurement due to surgical treatment of head and neck cancer.

Authors:  T-E Nogueira; M Adorno; E Mendonça; C Leles
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-03-01

4.  The impact of patient preference in the treatment algorithm for recurrent/metastatic head and neck squamous cell carcinoma.

Authors:  Viola Salvestrini; Carlotta Becherini; Isacco Desideri; Luisa Caprara; Matteo Mariotti; Marco Banini; Nicola Pierossi; Vieri Scotti; Lorenzo Livi; Pierluigi Bonomo
Journal:  Radiol Med       Date:  2022-06-25       Impact factor: 6.313

5.  Patients' experience of recurrent/metastatic head and neck squamous cell carcinoma and their perspective on the EORTC QLQ-C30 and QLQ-H&N35 questionnaires: a qualitative study.

Authors:  Arnold Degboe; Sarah L Knight; Katarina Halling; Andrew Trigg; Tamara Al-Zubeidi; Natalie Aldhouse; Helen Kitchen; Lori Wirth; Simon N Rogers
Journal:  J Patient Rep Outcomes       Date:  2018-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.